MIKKI SAPKOTA: Open Payments
NPI 1760006068 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 156 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $556 · 2025 $1,903
Food & beverage: $1,903
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 90 | $554 |
| ABBVIE INC. | 30 | $332 |
| Biogen, Inc. | 3 | $172 |
| Boston Scientific Corporation | 1 | $131 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| UCB, Inc. | 5 | $90 |
| ACADIA Pharmaceuticals Inc | 3 | $75 |
| EMD Serono, Inc. | 2 | $59 |
| PFIZER INC. | 3 | $55 |
Products named: AUSTEDO XR, QULIPTA, WATCHMAN FLX, VUMERITY, ZEPOSIA, REXULTI, UBRELVY, Fintepla.
Industry payments across PA — which companies pay providers there.
